Oxford Drug Design
Curated by SignalProvider of computer-aided design of antibiotics for MDR infections
Overview
Oxford Drug Design is a spinoff from the laboratory of Dr. Graham Richards at the University of Oxford and is focusing on developing novel antibiotics for multi-drug resistance bacterial infections. The company has developed a fast virtual screening and ligand analog searching platform to speed up the drug discovery process. Called 3D ElectroShape technology, the approach involves the use of their proprietary compound databases (containing over 23 million unique molecules), and a combination of structure- and ligand-based virtual screening to find ligands for target proteins.
Key facts
- Founded
- 2001
- Headquarters
- Oxford, United Kingdom
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view